In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells

Clin Immunol. 2005 Oct;117(1):73-7. doi: 10.1016/j.clim.2005.06.014.

Abstract

The in vitro effect of the hydrophilic statin - pravastatin - and three hydrophobic statins - atorvastatin, lovastatin and simvastatin - on the production of IL-1beta, IL-1ra, IL-2, IL-6 and IFN-gamma by human peripheral blood mononuclear cells (PBMC) and their response to mitogens was examined. Lovastatin and simvastatin increased the production of IL-1beta in a dose dependent manner and reduced secretion of IL-1ra at high concentration. These two statins exerted a dose dependent inhibitory effect on IL-2 production and reduced the secretion of IFNgamma at high dose. Atorvastatin did not affect IL-1beta, but suppressed IL-1ra, IL-2 and IFNgamma production. Atorvastatin, lovastatin and simvastatin caused a dose dependent inhibition of mitogen-induced proliferation of PBMC. IL-6 production was not affected by any one of the statins. While pravastatin caused a slight reduction in the proliferative response of PBMC to PHA, it did not affect either their response to Con A and PWM, or the secretion of cytokines tested.

Publication types

  • Comparative Study

MeSH terms

  • Atorvastatin
  • Cell Proliferation / drug effects*
  • Cytokines / biosynthesis
  • Cytokines / drug effects*
  • Heptanoic Acids / pharmacology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / pharmacology*
  • In Vitro Techniques
  • Leukocytes, Mononuclear / cytology
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / metabolism
  • Lovastatin / pharmacology
  • Mitogens / pharmacology
  • Pravastatin / pharmacology
  • Pyrroles / pharmacology
  • Simvastatin / pharmacology

Substances

  • Cytokines
  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Mitogens
  • Pyrroles
  • Lovastatin
  • Atorvastatin
  • Simvastatin
  • Pravastatin